00:00It's Benzinga, bringing Wall Street to Main Street.
00:02Amazon said Tuesday it is expanding into the weight loss market through a new GLP-1 management
00:07program under Amazon One Medical, according to CNBC. The program integrates obesity treatment
00:14into routine care with virtual and in-person visits, prescription management, and pharmacy
00:19fulfillment. Patients can access drugs including Wegevy and oral GLP-1 options through Amazon
00:25Pharmacy. Insured pricing starts at $25 per month, while oral drugs cost $149 per month
00:33for cash patients, and injectable treatments start at $299 per month. The company plans
00:40to expand same-day delivery to 4,500 cities by the end of 2026. Shares of obesity-related
00:47companies moved lower after the announcement. For all things money, visit Benzinga.com.
Comments